Avid Bioservices Inc (CDMO)

[jakedogman1]

Exactly. Twelve patients doesn't do diddly. Unless it's a special audience and the audience spells out what they need. I also think the patients will be more mainstream and geared towards answering "does this work in real situations" and not the worst of the worst patients that failed all other treatment.